Li Zong

Li Zong

Auto-generated profile, based on publicly available information

Li Zong

Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 211198, PR China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
MCMinglei Chen
Minglei Chen
KJKambere Amerigos Daddy J.C.
Kambere Amerigos Daddy J.C.
YXYanyu Xiao
Yanyu Xiao
QPQineng Ping
Qineng Ping
LZLi Zong
Li Zong
Rheumatoid arthritis (RA) is characterized by synovial inflammation and hyperplasia, autoantibody production, cartilage and bone destruction, and systemic features including cardiovascular, pulmona...

15 March 2018 in Diabetologia
Verified
Journal Article
Closed access
PDF file
YCYulin Chen
Yulin Chen
JWJie Wu
Jie Wu
JWJiajia Wang
Jiajia Wang
WZWenjing Zhang
Wenjing Zhang
BXBohui Xu
Bohui Xu
LZLi Zong
Li Zong

1 February 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
PBParikshit Banerjee
Parikshit Banerjee
TGTianjiao Geng
Tianjiao Geng
AMArpan Mahanty
Arpan Mahanty
TLTiantian Li
Tiantian Li
LZLi Zong
Li Zong
WBWang Bo
Wang Bo

1 June 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ZZZhaoyan Zeng
Zhaoyan Zeng
SDShuang Dai
Shuang Dai
YJYan Jiao
Yan Jiao
LJLei Jiang
Lei Jiang
YZYuekui Zhao
Yuekui Zhao
LZLi Zong
Li Zong

3 April 2018 in Journal of Drug Targeting
Verified
Journal Article
Closed access
BXBohui Xu
Bohui Xu
YXYan Xu
Yan Xu
GSGaoxing Su
Gaoxing Su
HZHongyan Zhu
Hongyan Zhu
LZLi Zong
Li Zong
Successful delivery of small interfering RNA (siRNA) into the cytoplasm of target cells relies on biocompatible and efficient vectors. In this study, a novel multifunctional core/shell nanoparticle [CS-SS-9R/BSA-c(RGDyK)] was developed to effectively deliver siVEGF to hepatocellular carcinoma cells (Bel-7402 cells). To improve the gene payload and transfection efficiency, a positively charged inner core (CS-SS-9R) was constructed by grafting nona-arginine (9R) onto chitosan (CS) using disulphide bonds. The negatively charged outer shell [BSA-c(RGDyK)] assembled on the surface of the inner core by electrostatic forces that shielded high cationic charges and provided improved targeting. The protein outer shell gradually detached from the inner core in the acidic lysosomal environment, leaving the cationic inner core exposed in order to escape from lysosomes. The nanoparticles were capable of delivering siVEGF into Bel-7402 cells via integrin receptor-mediated endocytosis. Successful lysosomal escape of the inner core and the rapid release of siVEGF into the cytoplasm resulted in a 78.9% decrease in VEGF expression and 81.2% inhibition of tumour cell proliferation. In conclusion, this nanoparticle is responsive to the intracellular environment and accurately delivered siRNA into the cytoplasm, providing a safe and highly efficient gene delivery strategy for cancer therapy.

27 February 2017 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
MXMenglu Xu
Menglu Xu
YCYulin Chen
Yulin Chen
PBParikshit Banerjee
Parikshit Banerjee
LZLi Zong
Li Zong
LJLei Jiang
Lei Jiang